Patent Assignment
Reel/Frame 029198/0396
Change of Name
Recorded: 2012-10-25
Pages: 5
Assignor
AMYLIN PHARMACEUTICALS, INC.
Executed: 2012-08-08
Assignee
AMYLIN PHARMACEUTICALS, LLC
9360 TOWNE CENTRE DRIVE, ATTN: INTELLECTUAL PROPERTY GROUP, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(23)
Exendin-4 to Treat Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease
Compositions and Methods for Treating Obesity and Related Metabolic Disorders
Application:
12/097,737 →
Publication:
US 2009/0209460
Amylin Agonists for Treating Cognitive Impairments
Application:
12/295,259 →
Publication:
US 2009/0181890
Novel Exendin and Glp-1 Peptides and Their Uses
Application:
12/301,199 →
Publication:
US 2010/0029554
DPP-IV Resistant GIP Hybrid Polypeptides with Selectable Properties
Formulation Delivery Device
Mixing Tool
Drug Delivery Device
Pen Injection Device and Method of Using Same
Peptide-Peptidase-Inhibitor Conjugates and Methods of Making and Using Same
Peptide-Peptidase Inhibitor Conjugates and Methods of Using Same
Glp-1 Receptor Agonist Bioassays
Exendins to Lower Cholesterol and Triglycerides
Application:
12/992,060 →
Publication:
US 2011/0263496
Sustained Release Formulations Using Non-Aqueous Carriers
Methods for Treating Diabetes and Reducing Body Weight
Methods for Affecting Body Composition Using Amylin Agonists
N-Terminus Conformationally Constrained Glp-1 Receptor Agonist Compounds
Amylin Agonist Compounds for Estrogen-Deficient Mammals
Application:
13/263,070 →
Publication:
US 2012/0071401
Amylin Family Peptides and Methods for Making and Using Them
Application:
13/445,803 →
Publication:
US 2012/0196799
Hypodermic Needle Assembly Having a Transition Hub for Enhancing Fluid Dynamics and Microsphere Injectability
Application:
13/520,965 →
Publication:
US 2013/0096531
Engineered Polypeptides Having Enhanced Duration of Action with Reduced Immunogenicity
Application:
61/585,577 →
Transmucosal Delivery of Engineered Polypeptides
Application:
61/616,961 →
Site-Specific Enzymatic Modification of Exendins and Analogs Thereof
Application:
61/637,393 →
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 20, 2009
From: FLEX PARTNERS, INC.
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 023549/0295 →
Assignment of Assignor's Interest
Jan 26, 2010
From: SMITH, CHRISTINE; HALILI, REY; QI, HONG
To: AMYLIN PHARMACEUTICALS, INC
Reel/Frame 023846/0365 →
Assignment of Assignor's Interest
Mar 2, 2011
From: HOUCHIN, MARY L.; LEE, ROBIN H.; QI, HONG; OEHRTMAN, GREG
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 025885/0811 →
Assignment of Assignor's Interest
Jul 18, 2012
From: DUFT, BRADFORD J.; KOLTERMAN, ORVILLE G.
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 028582/0168 →
Release of Security Interest
Oct 1, 2012
From: ELI LILLY AND COMPANY
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 029057/0342 →
Amylin Pharmaceuticals, Llc Assigns an Equal and Undivided One-Half of Its Entire Right, Title and Interest to Astrazeneca Pharmaceuticals Lp
Oct 26, 2012
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 029195/0555 →
Change of Name
Nov 1, 2012
From: AMYLIN PHARMACEUTICALS, INC.
To: AMYLIN PHARMACEUTICALS, LLC
Reel/Frame 029229/0637 →